A Study of MK-6194 (PT101) in Participants With Active Ulcerative Colitis (UC) (MK-6194-002)
Status:
Recruiting
Trial end date:
2023-01-26
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics,
pharmacodynamics and immunogenicity of MK-6194 in participants with active UC.